Cargando…

Nephrotoxicity of three formulations of amphotericin B: trial sequential analysis

Detalles Bibliográficos
Autores principales:	Caputo, Rosaria, Asprea, Martina, Giovannetti, Linda, Messori, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667437/ https://www.ncbi.nlm.nih.gov/pubmed/33224358 http://dx.doi.org/10.5114/aoms.2020.93338

Ejemplares similares

Comment on: Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching
por: Grothe, Jan, et al.
Publicado: (2022)

Renal Recovery following Liposomal Amphotericin B-Induced Nephrotoxicity
por: Personett, Heather A., et al.
Publicado: (2019)

Conventional Amphotericin B Associated Nephrotoxicity in Patients With Hematologic Malignancies
por: Gursoy, Vildan, et al.
Publicado: (2021)

Pentoxifylline in Prevention of Amphotericin B-induced Nephrotoxicity and Electrolyte Abnormalities
por: Panahi-Shokouh, Mahsa, et al.
Publicado: (2020)

Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)
por: Tuon, Felipe Francisco, et al.
Publicado: (2018)

1138. Retrospective Cohort Analysis of Amphotericin B Nephrotoxicity in Kidney Transplant Recipients
por: Assi, Mariam, et al.
Publicado: (2018)

Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
por: Efe İris, Nur, et al.
Publicado: (2016)

2109. Liposomal Amphotericin B-associated Nephrotoxicity in Obese and Non-obese Patients
por: Tritle, Brandon, et al.
Publicado: (2019)

Carbimazole induced nephrotoxicity
por: Rajesh, Reza, et al.
Publicado: (2021)

Vitamin D deficiency is a potential risk factor for lipid Amphotericin B nephrotoxicity
por: Ferreira, Daniela, et al.
Publicado: (2019)

601. Characterizing Modifiable Risk Factors for Liposomal Amphotericin B (L-AMB) Nephrotoxicity
por: Bialick, Kate, et al.
Publicado: (2022)

Amphotericin B Formulations and Other Drugs for Visceral Leishmaniasis
por: Berman, Jonathan
Publicado: (2015)

Design of amphotericin B oral formulation for antifungal therapy
por: Liu, Min, et al.
Publicado: (2017)

Trial sequential analysis: plain and simple
por: De Cassai, Alessandro, et al.
Publicado: (2021)

Severe Hypokalemia Precipitated Under Anesthesia Due to Conventional Amphotericin B in a Patient with Invasive Aspergillosis
por: Parida, Satyen, et al.
Publicado: (2021)

Caffeic Acid Phenethyl Ester Protects against Amphotericin B Induced Nephrotoxicity in Rat Model
por: Altuntaş, Atila, et al.
Publicado: (2014)

Predictive Nephrotoxicity Profiling of a Novel Antifungal Small Molecule in Comparison to Amphotericin B and Voriconazole
por: Udawatte, Nadeeka S., et al.
Publicado: (2020)

Nephrotoxicity in a Patient Treated with Pemetrexed
por: Zajjari, Y., et al.
Publicado: (2017)

Novel hollow biodegradable microneedle for amphotericin B delivery
por: Machekposhti, Sina Azizi, et al.
Publicado: (2023)

Effect of Erdosteine on Cyclosporine Induced Chronic Nephrotoxicity
por: Briguori, Carlo, et al.
Publicado: (2012)

Lithium Nephrotoxicity: When Is the Time for Nephrology Consultation?
por: SAVAJ, Shokoufeh, et al.
Publicado: (2016)

Losartan risk for female in cisplatin-induced nephrotoxicity
por: Nematbakhsh, Mehdi, et al.
Publicado: (2019)

Nephrotoxicity of Chloroquine and Hydroxychloroquine in COVID-19 Patients
por: Mahmoudi, Javad, et al.
Publicado: (2021)

Administration of amphotericin B in lipid emulsion decreases nephrotoxicity: a controlled study in critically ill patients
por: Sorkine, P, et al.
Publicado: (1997)

Frequency and Associated Factors of Amphotericin B Nephrotoxicity in Hospitalized Patients in Hematology-Oncology Wards in the Southwest of Iran
por: Karimzadeh, Iman, et al.
Publicado: (2016)

Desensitization to liposomal amphotericin B after anaphylaxis in a patient with COVID-19-associated mucormycosis – A case with review of literature
por: Swain, Satish, et al.
Publicado: (2022)

Hesperidin-, Curcumin-, and Amphotericin B- Based Nano-Formulations as Potential Antibacterials
por: Akbar, Noor, et al.
Publicado: (2022)

Review of Novel Oral Amphotericin B Formulations for the Treatment of Parasitic Infections
por: Wasan, Ellen, et al.
Publicado: (2022)

Repurposing Amphotericin B and Its Liposomal Formulation for the Treatment of Human Mpox
por: Peruzzu, Daniela, et al.
Publicado: (2023)

Amphotericin-B-liposomal/antibacterials/immunosuppressants: Various infections, nephrotoxicity and off-label use: 4 case reports
Publicado: (2022)

Insights into the Possible Mechanism of Cyclosporine-Induced Chronic Nephrotoxicity; Arteriolopathy
por: Yoon, Sang Pil
Publicado: (2012)

The Protective Role of Silymarin and Aerobic Exercise on Gentamicin-induced Nephrotoxicity
por: Alavijeh, Fatemeh Shafiei, et al.
Publicado: (2019)

Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B
por: Skipper, Caleb P., et al.
Publicado: (2020)

New Insight of OCT2 Regulation as Mediator for Cisplatin- Induced Nephrotoxicity
por: EL-Arabey, Amr Ahmed, et al.
Publicado: (2017)

Amphotericin B lipid formulations and target-site penetration into human body fluids
por: Weiler, Stefan, et al.
Publicado: (2008)

Confusion between Two Amphotericin B Formulations Leading to a Paediatric Rehospitalisation
por: Fleury, Mapi, et al.
Publicado: (2016)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Tolerability and epidemiology of nephrotoxicity associated with conventional amphotericin B therapy: a retrospective study in tertiary care centers in Palestine
por: Abdel-Hafez, Yusri, et al.
Publicado: (2022)

Differences in Effectiveness among Devices for Endovascular Thrombectomy in Patients with Acute Ischemic Stroke
por: Chiumente, Marco, et al.
Publicado: (2016)

Axicabtagene ciloleucel in non-Hodgkin lymphoma: the restricted mean survival time as a tool for estimating progression-free life expectancy better than the median
por: Messori, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g7m4vq1l3dt6jhfmq7ai9v7ev6